1271831

IPR Pharmaceuticals, Inc. — FEI 3003009422

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 12, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Canovanas, PR (United States)